Asiedu EB, Kumar A, Choi A, Luciano DO, et al. Targeting the ANGPTL4/NRP1/ABL1/RAD51 axis reverses cisplatin resistance by impairing DNA damage repair in head and neck cancer. Proc Natl Acad Sci U S A 2026;123:e2510265123.
PMID: 41886374